StockData
Travere Therapeutics, Inc. logo

Travere Therapeutics, Inc. (TVTX) stock

TVTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 6/30751% above fair value
$50.24−0.86 (-1.68%)

Close on Nov 18, 2026Market cap $4.74BP/E –Yield –

Travere Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Travere Therapeutics's market cap was $4.90B on Nov 11, 2026, against $3.17B a year earlier. Over the last 5 years it ranged from $416.78M to $6.24B, with a median of $1.48B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$4.90B+43.4%
2025Dec 31, 2025$3.42B+151.9%
2024Dec 31, 2024$1.36B+101.0%
2023Dec 29, 2023$675.25M-49.9%
2022Dec 30, 2022$1.35B-28.8%
2021Dec 31, 2021$1.89B+36.2%
2020Dec 31, 2020$1.39B+128.0%
2019Dec 31, 2019$610.01M-34.5%
2018Dec 31, 2018$931.63M+12.6%
2017Dec 29, 2017$827.64M+16.0%
2016Dec 30, 2016$713.74M+2.8%
2015Dec 31, 2015$694.60M+115.6%
2014Dec 31, 2014$322.16M+150.4%
2013Dec 31, 2013$128.63M+35888.9%
2012Dec 31, 2012$357.43K–

More Travere Therapeutics figures

See a number that looks wrong?